US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 113.740
  • -9.110-7.42%
Close Jan 13 16:00 ET
  • 113.740
  • 0.0000.00%
Post 17:22 ET
27.27BMarket Cap-57.24P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioNTech Q4 2024 Estimates Date

Currency：USDMar 10, 2025

Estimate YoY
Revenue
1.20B
-26.63%
EPS
0.43
-79.61%
Analyst Rating
Strong Buy

Jan 13, 2025

BioNTech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 5, 20252025/Q1-- / 187.667M--
Mar 10, 20252024/Q4-- / 1.151B--
Nov 4, 20242024/Q31.245B / 516.021M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--
DatePeriodRevenue/EstimateEarnings Call
May 5, 20252025/Q1-- / 187.667M--
Mar 10, 20252024/Q4-- / 1.151B--
Nov 4, 20242024/Q31.245B / 516.021M--
Aug 5, 20242024/Q2128.700M / 135.687M--
May 6, 20242024/Q1187.600M / 372.284M--

Unlock Free Earnings Estimates

BioNTech Earnings Reports

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 4, 2024 19:59

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 4, 2024 19:59

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5, 2024 18:37

  • BioNTech | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 5, 2024 18:37

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 13, 2025

    Strong Buy

    • Buy

      82.35%

    • Hold

      17.65%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday+0.36%